Resonac Partners with Matmerize to Pioneer 6G Technology Advancement using Innovative AI Software 6-09-2023, 21:25

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Enernet Global Signs Power Purchase Agreement for 12MW Solar With Vedanta Zinc International in South Africa 8-09-2023, 09:18